Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Ailliance Post-Market Clinical Study

NCT: NCT05856370 · RECRUITING

NCT IDNCT05856370
StatusRECRUITING
Start Date2023-05-01
Completion2031-05

Brief Summary

The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.

Frequently Asked Questions

What is The Ailliance Post-Market Clinical Study?

The Ailliance Post-Market Clinical Study is a clinical trial registered under NCT05856370. Current status: RECRUITING.

What is the status of NCT05856370?

The current status of NCT05856370 (The Ailliance Post-Market Clinical Study) is: RECRUITING.

When did The Ailliance Post-Market Clinical Study start?

The Ailliance Post-Market Clinical Study started on 2023-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.